Global Anaphylaxis Treatment Markets 2021-2028



Dublin, August 11, 2021 (GLOBE NEWSWIRE) – The “Anaphylaxis Treatment Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Drug Type, Route of Administration, Allergy Type and Distribution Channel” report was added to offer.

New drug delivery systems to promote the growth of the anaphylaxis treatment market in the period 2021-2028

The anaphylaxis treatment market is expected to reach US $ 4,787.66 million in 2028 compared to US $ 2,664.66 million in 2021; it is estimated to increase at a CAGR of 8.7% from 2021 to 2028.

New drug delivery systems support improved drug potency and controlled drug release, while providing sustained therapeutic effect for reliable safety. Many drugs have a maximum concentration range for maximum benefit, and higher or lower concentrations may be toxic or not produce any medicinal use.

Further, it is explained that various drug delivery and drug targeting systems have the ability to minimize drug degradation as well as prevent harmful side effects. Intramuscular injection of epinephrine is normally underused in anaphylaxis, mainly due to unavailability or inaccessibility. The drugs offer the convenience of a wide range of painless multiple doses, especially for children, if needed, for the emergency out-of-hospital treatment of anaphylaxis.

According to the article recently published by Nova Southeastern University, epinephrine can be administered sublingually using a new formulation of rapidly dissolving tablets. However, the relative sublingual bioavailability of epinephrine in tablet form is low. Therefore, this proposal aims to further discuss tablets that will dramatically improve the bioavailability of sublingual epinephrine.

Geographically, the anaphylaxis treatment market is segmented into North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In North America, the United States holds the largest share of the North American anaphylaxis treatment market.

The growth of the anaphylaxis treatment market in the United States is determined due to factors such as easy access to allergy medications, increasing incidence of allergic reactions, and increasing government policies to access epinephrine to school children. In addition, the growing number of product launches for generic drugs dominate the epinephrine market in the region.

The market in Canada and Mexico is expected to grow due to the increasing supply of generic versions of anaphylaxis drugs by various market players. Furthermore, the increase in the incidence of anaphylaxis in these countries is likely to worsen owing to the growth of the anaphylaxis treatment market during the forecast period.

Main topics covered:

1. Introduction
1.1 Scope of the study
1.2 Orientation of the research report
1.3 Market segmentation

2. Anaphylaxis Treatment Market – Key Points to Remember

3. Research methodology
3.1 Coverage
3.2 Secondary research
3.3 Primary research

4. Global Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST analysis
4.3 Expert advice

5. Anaphylaxis Treatment Market – Key Market Dynamics
5.1 Market drivers
5.1.1 Increased incidence of anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market restrictions
5.2.1 Limited access to epinephrine auto-injectors in low-income countries
5.3 Market opportunities
5.3.1 Increased cases of allergies after administration of COVID-19 vaccines
5.4 Future trends
5.4.1 New drug delivery systems
5.5 Impact analysis

6.Anaphylaxis Treatment Market – Global Analysis
6.1 Global Anaphylaxis Treatment Market Forecast and Revenue Analysis
6.2 Global Anaphylaxis Treatment Market, By Geography – Forecast and Analysis
6.3 Market positioning of key players

7. Anaphylaxis Treatment Market Analysis – By Drug Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Drug Type (2020 and 2028)
7.3 Epinephrine
7.4 Antihistamines
7.5 Steroids
7.6 Beta-agonist

8.Anaphylaxis Treatment Market Analysis – By Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, By Administration (2020 and 2028)
8.3 Oral
8.4 Parenteral

9. Anaphylaxis Treatment Market Analysis – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food allergy
9.4 Medicines
9.5 Insect bites

10. Anaphylaxis Treatment Market Analysis and Forecast – By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail sales
10.4 Hospital pharmacies

11. Global Anaphylaxis Treatment Market – Geographic Analysis

12. Impact of the COVID-19 pandemic on the global anaphylaxis treatment market

13. Anaphylaxis Treatment Market and Industry Landscape
13.1 Overview
13.2 Growth strategies implemented by market companies, (%)
13.3 Organic developments
13.4 Inorganic developments

14. Company profiles
14.1 Key facts
14.2 Company description
14.3 Products and services
14.4 Financial overview
14.5 SWOT analysis
14.6 Key developments

  • Amneal Pharmaceuticals Inc.
  • Bioproject
  • Mylan NV
  • Pharmaceutical company Adamis
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck et Cie., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-Abello

For more information on this report, visit


Leave A Reply

Your email address will not be published.